During this time, you may still experience side effects, though they will likely ease as the drug level in your body drops
Adverse reactions and tolerability: Since they are administered via injection and affect gastric emptying (particularly in the case of shorter-acting agents), GLP-1 receptor agonists present some tolerability concerns
The NDSS is an initiative of the Australian Government administered by Diabetes Australia
Each injection delivers a precisely measured dose of semaglutide that activates GLP-1 receptors at therapeutic concentrationsa level of specificity and potency no OTC supplement can match
The technical term is it's a GLP-1 receptor agonist, and just like GLP-1, it increases insulin release, it lowers blood sugar, the stomach empties slower, but it was different from GLP-1 in one really important way